MEDIFAST INC
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. … Read more
MEDIFAST INC (MED) - Total Assets
Latest total assets as of September 2025: $268.21 Million USD
Based on the latest financial reports, MEDIFAST INC (MED) holds total assets worth $268.21 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MEDIFAST INC - Total Assets Trend (1996–2024)
This chart illustrates how MEDIFAST INC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MEDIFAST INC - Asset Composition Analysis
Current Asset Composition (December 2024)
MEDIFAST INC's total assets of $268.21 Million consist of 75.4% current assets and 24.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $90.93 Million | 32.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $42.42 Million | 14.9% |
| Property, Plant & Equipment | $48.68 Million | 17.1% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1996–2024)
This chart illustrates how MEDIFAST INC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MEDIFAST INC's current assets represent 75.4% of total assets in 2024, an increase from 54.4% in 1996.
- Cash Position: Cash and equivalents constituted 32.0% of total assets in 2024, up from 2.5% in 1996.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 1996.
- Asset Diversification: The largest asset category is cash and equivalents at 32.0% of total assets.
MEDIFAST INC Competitors by Total Assets
Key competitors of MEDIFAST INC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Da Lue International Holding Co Ltd
TWO:4804
|
Taiwan | NT$384.89 Million |
|
Lungyen Life Service
TWO:5530
|
Taiwan | NT$77.05 Billion |
|
Hube Yangfan Holding Co Ltd
SHG:600421
|
China | CN¥183.02 Million |
|
Af Legal Group Ltd
AU:AFL
|
Australia | AU$27.86 Million |
|
Apiam Animal Health Ltd
AU:AHX
|
Australia | AU$255.80 Million |
|
Lepermislibre Sa
PA:ALLPL
|
France | €4.38 Million |
|
Andersen Group Inc.
NYSE:ANDG
|
USA | $563.07 Million |
|
Bright Horizons Family Solutions Inc
NYSE:BFAM
|
USA | $4.15 Billion |
MEDIFAST INC - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - MEDIFAST INC generates 2.12x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, MEDIFAST INC generates $ 0.74 in net profit.
MEDIFAST INC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.45 | 3.11 | 2.10 |
| Quick Ratio | 3.95 | 2.55 | 1.62 |
| Cash Ratio | 2.13 | 1.59 | 0.00 |
| Working Capital | $161.12 Million | $ 152.60 Million | $ 122.96 Million |
MEDIFAST INC - Advanced Valuation Insights
This section examines the relationship between MEDIFAST INC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.55 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -8.3% |
| Total Assets | $284.21 Million |
| Market Capitalization | $92.13 Million USD |
Valuation Analysis
Below Book Valuation: The market values MEDIFAST INC's assets below their book value (0.32 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MEDIFAST INC's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MEDIFAST INC (1996–2024)
The table below shows the annual total assets of MEDIFAST INC from 1996 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $284.21 Million | -8.29% |
| 2023-12-31 | $309.91 Million | -1.99% |
| 2022-12-31 | $316.21 Million | -20.61% |
| 2021-12-31 | $398.33 Million | +44.28% |
| 2020-12-31 | $276.08 Million | +41.83% |
| 2019-12-31 | $194.65 Million | +14.89% |
| 2018-12-31 | $169.43 Million | +16.10% |
| 2017-12-31 | $145.93 Million | +20.39% |
| 2016-12-31 | $121.22 Million | +3.32% |
| 2015-12-31 | $117.33 Million | +1.22% |
| 2014-12-31 | $115.91 Million | -12.62% |
| 2013-12-31 | $132.65 Million | +1.84% |
| 2012-12-31 | $130.25 Million | +23.27% |
| 2011-12-31 | $105.67 Million | +12.34% |
| 2010-12-31 | $94.06 Million | +46.65% |
| 2009-12-31 | $64.14 Million | +25.67% |
| 2008-12-31 | $51.04 Million | +16.73% |
| 2007-12-31 | $43.72 Million | +18.41% |
| 2006-12-31 | $36.93 Million | +20.89% |
| 2005-12-31 | $30.55 Million | +17.63% |
| 2004-12-31 | $25.97 Million | +7.16% |
| 2003-12-31 | $24.23 Million | +145.06% |
| 2002-12-31 | $9.89 Million | +194.55% |
| 2001-12-31 | $3.36 Million | +7.42% |
| 2000-12-31 | $3.12 Million | +47.96% |
| 1999-12-31 | $2.11 Million | -79.57% |
| 1998-12-31 | $10.34 Million | +48.91% |
| 1997-12-31 | $6.94 Million | -39.36% |
| 1996-12-31 | $11.45 Million | -- |